Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Compliance is the biggest challenge in patients with Short Bowel Syndrome (SBS) on Home Parenteral Nutrition. These patients need to hydrate themselves to meet the excess fluid loss due to their anatomy. Oral Rehydration Solution (ORS) is prescribed to all these patients. The investigators believe that taste of the standard ORS is the biggest reason why these patients are not complaint. The new ORS in the market has been prepared with this in mind. The investigators want to study if this new ORS will improve the compliance in this patient cohort.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| WHO ORS | Active Comparator | Participants will be instructed to dilute contents of the provided ORS to a 1 liter bottle and sip all day. |
|
| Commercial ORS | Active Comparator | Participants will be instructed to dilute contents of the provided ORS to a 1 liter bottle and sip all day. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| WHO ORS | Dietary Supplement | Participants will be randomized into one of the two groups. They will be provided with one of the two ORS solutions. Then, they will be followed for 6 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients who will regularly take Oral Rehydration Solution (ORS) when the newly available ORS is compared to the World Health Organisation ORS. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in the electrolytes in subjects using the commercial ORS versus the WHO ORS | Baseline to 6 months |
Not provided
Inclusion Criteria
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ryan Hurt, MD, PhD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| ID | Term |
|---|---|
| D012778 | Short Bowel Syndrome |
| D010349 | Patient Compliance |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D008286 | Malabsorption Syndromes |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C044142 | World Health Organization oral rehydration solution |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Commercial ORS | Dietary Supplement | Participants will be instructed to dilute contents of the provided ORS to a 1 liter bottle and sip all day. |
|
|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |